Aryl sulfonamides

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/12 (2006.01) A61K 31/44 (2006.01) A61P 29/00 (2006.01) C07D 213/26 (2006.01) C07D 213/50 (2006.01) C07D 213/70 (2006.01) C07D 213/74 (2006.01) C07D 213/84 (2006.01) C07D 213/89 (2006.01) C07D 241/12 (2006.01)

Patent

CA 2500492

Compounds of formula (I) (in which the variables L, X, Y and Z are as defined in the claims) are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulphonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.

L'invention concerne des composés qui agissent comme puissants antagonistes du récepteur CCR9, et qui ont été en outre confirmés dans des essais animaux d'inflammation, un état pathologique caractéristique du CCR9. Les composés, d'ordinaire des dérivés d'arylsulfonamides, sont utilisés dans compositions pharmaceutiques, des procédés de traitement de maladies médiées par CCR9, et comme témoins dans des analyses d'identification d'antagonistes du CCR9.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryl sulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl sulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl sulfonamides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1785660

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.